Anzeige
Mehr »
Dienstag, 28.10.2025 - Börsentäglich über 12.000 News
Atomkraft feiert Comeback: Uran wird wieder zum strategischen Rohstoff - Anleger stehen Schlange
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Pharmaceutical Technology

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
15.10.Nabla Bio expands Takeda collab for protein therapeutics
15.10.BioCryst to buy Astria Therapeutics for $700m in enterprise value
14.10.J&J spins off orthopaedics business against positive Q3 backdrop
14.10.Kailera nets $600m to power Phase III launch of obesity drug
14.10.China's drugs offer lifeline for global pharma as it peers over the patent cliff
14.10.FDA approves AbbVie's Rinvoq for inflammatory bowel disease
14.10.CIPO grants patent to Palisade Bio's PALI-2108
13.10.BIOSECURE returns to US pharma agenda with 2.0 update
13.10.AstraZeneca inks Trump drug pricing deal amid tariff threats
13.10.J&J in talks to acquire Protagonist Therapeutics
13.10.FDA approves Teva and Medincell's bipolar I disorder treatment
10.10.BMS expands CAR-T portfolio with $1.5bn Orbital buyout
10.10.AstraZeneca sets $4.5bn Virginia API plant construction in motion
10.10.Flu vaccine uptake increases 28% in England
10.10.FDA approves Celltrion's Eydenzelt for eye diseases
10.10.Turbine and AstraZeneca partner for ADC discovery
09.10.Boehringer's Jascayd nets first FDA IPF approval in over 10 years
09.10.Novo Nordisk buys MASH specialist Akero for up to $5.2bn
09.10.Amazon Pharmacy kiosks to provide prescription medications in minutes
09.10.Arthrosi gains $153m for development of gout therapy
09.10.FDA approves Regeneron's Libtayo for high-risk CSCC post-surgery
08.10.China accounts for one-fifth of global drugs in development
08.10.Ex-FDA chief Peter Marks joins Eli Lilly's infectious disease unit
08.10.MapLight's $251m IPO sees schizophrenia drug developers on top
08.10.Affinia raises $40m for gene therapy development